InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the detailed record of transactions filed by Farnum Rhonda, Directrice Exécutive et Responsable des Affaires Médicales. Officer active across 1 company, notably Theravance Biopharma, Inc.. Aggregated, 5 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €21k. History available since 14 December 2021. The latest transaction was filed on 20 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations5 total
2,200 shares@ US$8.740.0022% mcap13.0% of flowOrdinary SharesSEC:0001415889-22-005627:0
2,356 shares@ US$10.16410.0026% mcap15.3% of flowOrdinary SharesSEC:0001415889-22-002174:0
11,824 shares@ US$9.610.012% mcap71.6% of flowOrdinary SharesSEC:0001415889-22-001695:0
27,500 shares0Ordinary SharesSEC:0001179110-21-011076
27,500 shares0Ordinary SharesSEC:0001179110-21-011076:0
5 of 5 declarations
About Farnum Rhonda
Rhonda Farnum serves as Executive Vice President and Chief of Communications & Medical Affairs at Theravance Biopharma, Inc. She oversees operations related to medical affairs and communications. Her role is essential to ensure compliance and effectiveness of the company's medical initiatives.
